Cargando…

Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease

BACKGROUND: In patients with Parkinson’s disease (PD), real-time quaking-induced conversion (RT-QuIC) detection of pathological α-synuclein (α-syn) in olfactory mucosa (OM) is not as accurate as in other α-synucleinopathies. It is unknown whether these variable results might be related to a differen...

Descripción completa

Detalles Bibliográficos
Autores principales: Bongianni, Matilde, Catalan, Mauro, Perra, Daniela, Fontana, Elena, Janes, Francesco, Bertolotti, Claudio, Sacchetto, Luca, Capaldi, Stefano, Tagliapietra, Matteo, Polverino, Paola, Tommasini, Valentina, Bellavita, Giulia, Kachoie, Elham Ataie, Baruca, Roberto, Bernardini, Andrea, Valente, Mariarosaria, Fiorini, Michele, Bronzato, Erika, Tamburin, Stefano, Bertolasi, Laura, Brozzetti, Lorenzo, Cecchini, Maria Paola, Gigli, Gianluigi, Monaco, Salvatore, Manganotti, Paolo, Zanusso, Gianluigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330656/
https://www.ncbi.nlm.nih.gov/pubmed/35902902
http://dx.doi.org/10.1186/s40035-022-00311-3
_version_ 1784758215489093632
author Bongianni, Matilde
Catalan, Mauro
Perra, Daniela
Fontana, Elena
Janes, Francesco
Bertolotti, Claudio
Sacchetto, Luca
Capaldi, Stefano
Tagliapietra, Matteo
Polverino, Paola
Tommasini, Valentina
Bellavita, Giulia
Kachoie, Elham Ataie
Baruca, Roberto
Bernardini, Andrea
Valente, Mariarosaria
Fiorini, Michele
Bronzato, Erika
Tamburin, Stefano
Bertolasi, Laura
Brozzetti, Lorenzo
Cecchini, Maria Paola
Gigli, Gianluigi
Monaco, Salvatore
Manganotti, Paolo
Zanusso, Gianluigi
author_facet Bongianni, Matilde
Catalan, Mauro
Perra, Daniela
Fontana, Elena
Janes, Francesco
Bertolotti, Claudio
Sacchetto, Luca
Capaldi, Stefano
Tagliapietra, Matteo
Polverino, Paola
Tommasini, Valentina
Bellavita, Giulia
Kachoie, Elham Ataie
Baruca, Roberto
Bernardini, Andrea
Valente, Mariarosaria
Fiorini, Michele
Bronzato, Erika
Tamburin, Stefano
Bertolasi, Laura
Brozzetti, Lorenzo
Cecchini, Maria Paola
Gigli, Gianluigi
Monaco, Salvatore
Manganotti, Paolo
Zanusso, Gianluigi
author_sort Bongianni, Matilde
collection PubMed
description BACKGROUND: In patients with Parkinson’s disease (PD), real-time quaking-induced conversion (RT-QuIC) detection of pathological α-synuclein (α-syn) in olfactory mucosa (OM) is not as accurate as in other α-synucleinopathies. It is unknown whether these variable results might be related to a different distribution of pathological α-syn in OM. Thus, we investigated whether nasal swab (NS) performed in areas with a different coverage by olfactory neuroepithelium, such as agger nasi (AN) and middle turbinate (MT), might affect the detection of pathological α-syn. METHODS: NS was performed in 66 patients with PD and 29 non-PD between September 2018 and April 2021. In 43 patients, cerebrospinal fluid (CSF) was also obtained and all samples were analyzed by RT-QuIC for α-syn. RESULTS: In the first round, 72 OM samples were collected by NS, from AN (NS(AN)) or from MT (NS(MT)), and 35 resulted positive for α-syn RT-QuIC, including 27/32 (84%) from AN, 5/11 (45%) from MT, and 3/29 (10%) belonging to the non-PD patients. Furthermore, 23 additional PD patients underwent NS at both AN and MT, and RT-QuIC revealed α-syn positive in 18/23 (78%) NS(AN) samples and in 10/23 (44%) NS(MT) samples. Immunocytochemistry of NS preparations showed a higher representation of olfactory neural cells in NS(AN) compared to NS(MT). We also observed α-syn and phospho-α-syn deposits in NS from PD patients but not in controls. Finally, RT-QuIC was positive in 22/24 CSF samples from PD patients (92%) and in 1/19 non-PD. CONCLUSION: In PD patients, RT-QuIC sensitivity is significantly increased (from 45% to 84%) when NS is performed at AN, indicating that α-syn aggregates are preferentially detected in olfactory areas with higher concentration of olfactory neurons. Although RT-QuIC analysis of CSF showed a higher diagnostic accuracy compared to NS, due to the non-invasiveness, NS might be considered as an ancillary procedure for PD diagnosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40035-022-00311-3.
format Online
Article
Text
id pubmed-9330656
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93306562022-07-28 Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease Bongianni, Matilde Catalan, Mauro Perra, Daniela Fontana, Elena Janes, Francesco Bertolotti, Claudio Sacchetto, Luca Capaldi, Stefano Tagliapietra, Matteo Polverino, Paola Tommasini, Valentina Bellavita, Giulia Kachoie, Elham Ataie Baruca, Roberto Bernardini, Andrea Valente, Mariarosaria Fiorini, Michele Bronzato, Erika Tamburin, Stefano Bertolasi, Laura Brozzetti, Lorenzo Cecchini, Maria Paola Gigli, Gianluigi Monaco, Salvatore Manganotti, Paolo Zanusso, Gianluigi Transl Neurodegener Research BACKGROUND: In patients with Parkinson’s disease (PD), real-time quaking-induced conversion (RT-QuIC) detection of pathological α-synuclein (α-syn) in olfactory mucosa (OM) is not as accurate as in other α-synucleinopathies. It is unknown whether these variable results might be related to a different distribution of pathological α-syn in OM. Thus, we investigated whether nasal swab (NS) performed in areas with a different coverage by olfactory neuroepithelium, such as agger nasi (AN) and middle turbinate (MT), might affect the detection of pathological α-syn. METHODS: NS was performed in 66 patients with PD and 29 non-PD between September 2018 and April 2021. In 43 patients, cerebrospinal fluid (CSF) was also obtained and all samples were analyzed by RT-QuIC for α-syn. RESULTS: In the first round, 72 OM samples were collected by NS, from AN (NS(AN)) or from MT (NS(MT)), and 35 resulted positive for α-syn RT-QuIC, including 27/32 (84%) from AN, 5/11 (45%) from MT, and 3/29 (10%) belonging to the non-PD patients. Furthermore, 23 additional PD patients underwent NS at both AN and MT, and RT-QuIC revealed α-syn positive in 18/23 (78%) NS(AN) samples and in 10/23 (44%) NS(MT) samples. Immunocytochemistry of NS preparations showed a higher representation of olfactory neural cells in NS(AN) compared to NS(MT). We also observed α-syn and phospho-α-syn deposits in NS from PD patients but not in controls. Finally, RT-QuIC was positive in 22/24 CSF samples from PD patients (92%) and in 1/19 non-PD. CONCLUSION: In PD patients, RT-QuIC sensitivity is significantly increased (from 45% to 84%) when NS is performed at AN, indicating that α-syn aggregates are preferentially detected in olfactory areas with higher concentration of olfactory neurons. Although RT-QuIC analysis of CSF showed a higher diagnostic accuracy compared to NS, due to the non-invasiveness, NS might be considered as an ancillary procedure for PD diagnosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40035-022-00311-3. BioMed Central 2022-07-28 /pmc/articles/PMC9330656/ /pubmed/35902902 http://dx.doi.org/10.1186/s40035-022-00311-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Bongianni, Matilde
Catalan, Mauro
Perra, Daniela
Fontana, Elena
Janes, Francesco
Bertolotti, Claudio
Sacchetto, Luca
Capaldi, Stefano
Tagliapietra, Matteo
Polverino, Paola
Tommasini, Valentina
Bellavita, Giulia
Kachoie, Elham Ataie
Baruca, Roberto
Bernardini, Andrea
Valente, Mariarosaria
Fiorini, Michele
Bronzato, Erika
Tamburin, Stefano
Bertolasi, Laura
Brozzetti, Lorenzo
Cecchini, Maria Paola
Gigli, Gianluigi
Monaco, Salvatore
Manganotti, Paolo
Zanusso, Gianluigi
Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease
title Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease
title_full Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease
title_fullStr Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease
title_full_unstemmed Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease
title_short Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease
title_sort olfactory swab sampling optimization for α-synuclein aggregate detection in patients with parkinson’s disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330656/
https://www.ncbi.nlm.nih.gov/pubmed/35902902
http://dx.doi.org/10.1186/s40035-022-00311-3
work_keys_str_mv AT bongiannimatilde olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease
AT catalanmauro olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease
AT perradaniela olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease
AT fontanaelena olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease
AT janesfrancesco olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease
AT bertolotticlaudio olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease
AT sacchettoluca olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease
AT capaldistefano olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease
AT tagliapietramatteo olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease
AT polverinopaola olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease
AT tommasinivalentina olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease
AT bellavitagiulia olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease
AT kachoieelhamataie olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease
AT barucaroberto olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease
AT bernardiniandrea olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease
AT valentemariarosaria olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease
AT fiorinimichele olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease
AT bronzatoerika olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease
AT tamburinstefano olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease
AT bertolasilaura olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease
AT brozzettilorenzo olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease
AT cecchinimariapaola olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease
AT gigligianluigi olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease
AT monacosalvatore olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease
AT manganottipaolo olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease
AT zanussogianluigi olfactoryswabsamplingoptimizationforasynucleinaggregatedetectioninpatientswithparkinsonsdisease